{"id":"W3096504089","doi":"10.1016/j.ophtha.2020.10.036","title":"Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis","year":2020,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Medical Research Council; Allergan; Genentech; Alimera Sciences; Santen; Regeneron Pharmaceuticals; Gilead Sciences; Celldex Therapeutics; Pfizer; Aldeyra Therapeutics; NightstaRx; AbbVie; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Uveitis; Visual acuity; Placebo; Adverse effect; Intermediate uveitis; Macular edema; Ophthalmology; Corticosteroid; Surgery; Internal medicine; Anterior uveitis; Pathology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001420415,0.0003308087,0.0008994464,0.0003143372,0.0005649716,0.0009190666,0.0002519445,0.0005254288,0.0008573339],"category_scores_gemma":[0.001955674,0.000158889,0.001065125,0.0003401698,0.0003580452,0.0006997272,0.0002311271,0.001257147,0.0002433706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000559,"about_ca_system_score_gemma":0.0005020253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007821256,"about_ca_topic_score_gemma":0.001188821,"domain_scores_codex":[0.9994979,0.0001246576,0.00007635925,0.0000799592,0.00009245817,0.0001286769],"domain_scores_gemma":[0.9987283,0.0003674727,0.0003583326,0.00009929823,0.0001306217,0.0003159169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1699804,0.004588379,0.63424,0.0007236404,0.003590109,0.001310937,0.0004986693,0.001178876,0.01437461,0.0002472169,0.001502542,0.1677645],"study_design_scores_gemma":[0.007020505,0.04645439,0.933821,0.0001308174,0.002403885,0.001747161,0.0003121848,0.001595256,0.002860843,0.0002751983,0.00330691,0.00007200403],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923357,0.006368351,0.000098871,0.000144573,0.00004028812,0.00001558265,0.0001567926,0.00000911511,0.0008306394],"genre_scores_gemma":[0.9987516,0.0005176046,0.00005578964,0.0001565749,0.00006535134,0.00001199903,0.0002246291,0.0000016872,0.0002147696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001420415,"threshold_uncertainty_score":0.007511914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01205284802840153,"score_gpt":0.2627004603660731,"score_spread":0.2506476123376716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}